SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-462898
Filing Date
2012-11-09
Accepted
2012-11-09 14:36:18
Documents
15
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d403453d10q.htm 10-Q 752546
2 SECOND AMENDMENT TO LEASE d403453dex101.htm EX-10.1 30754
3 FIRST LOAN MODIFICATION AGREEMENT d403453dex102.htm EX-10.2 33436
4 FRASER EMPLOYMENT AGREEMENT d403453dex103.htm EX-10.3 55207
5 SECTION 302 CEO CERTIFICATION d403453dex311.htm EX-31.1 10575
6 SECTION 302 CFO CERTIFICATION d403453dex312.htm EX-31.2 10596
7 SECTION 906 CEO CERTIFICATION d403453dex321.htm EX-32.1 4832
8 SECTION 906 CFO CERTIFICATION d403453dex322.htm EX-32.2 4853
15 GRAPHIC g403453ex10_1pg005.jpg GRAPHIC 168927
  Complete submission text file 0001193125-12-462898.txt   4656140

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT aegr-20120930.xml EX-101.INS 621799
10 XBRL TAXONOMY EXTENSION SCHEMA aegr-20120930.xsd EX-101.SCH 40348
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aegr-20120930_cal.xml EX-101.CAL 58029
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aegr-20120930_def.xml EX-101.DEF 203422
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE aegr-20120930_lab.xml EX-101.LAB 296597
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aegr-20120930_pre.xml EX-101.PRE 242650
Mailing Address 101 MAIN STREET SUITE 1850 CAMBRIDGE MA 02142
Business Address 101 MAIN STREET SUITE 1850 CAMBRIDGE MA 02142 (617) 500-7867
Aegerion Pharmaceuticals, Inc. (Filer) CIK: 0001338042 (see all company filings)

IRS No.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34921 | Film No.: 121193090
SIC: 2834 Pharmaceutical Preparations